-transparent.png){kind=logo}
We have verified the local activity and tolerance of the antimycotic drug ciclopiroxolamine in an open trial. The study included 34 women suffering from clinically and mycologically diagnosed vulvovaginitis caused by Candida. The therapy consisted of inserting a 100 mg ovule of ciclopiroxolamine once a day for 3 days. The cultural examination was negative in 76.5% of cases at the 1st control after the treatment and in 82.3% of cases at the 2nd control after the treatment. All the considered subjective and objective symptoms showed a highly significant decrease of frequency and intensity. No chemical parameter was modified; only in one patient a very mild side effect was verified.
A Bucciero, and
E Molteni, and
B Molteni, and
W Mariani, and
M Jacobellis
March 1988,
Minerva pediatrica,
A Bucciero, and
E Molteni, and
B Molteni, and
W Mariani, and
M Jacobellis
November 1968,
Zeitschrift fur Haut- und Geschlechtskrankheiten,
A Bucciero, and
E Molteni, and
B Molteni, and
W Mariani, and
M Jacobellis
December 1975,
Semaine des hopitaux. Therapeutique,
A Bucciero, and
E Molteni, and
B Molteni, and
W Mariani, and
M Jacobellis
July 1965,
Das Deutsche Gesundheitswesen,
A Bucciero, and
E Molteni, and
B Molteni, and
W Mariani, and
M Jacobellis
January 1996,
Fortschritte der Medizin,
A Bucciero, and
E Molteni, and
B Molteni, and
W Mariani, and
M Jacobellis
April 1989,
Mycoses,
A Bucciero, and
E Molteni, and
B Molteni, and
W Mariani, and
M Jacobellis
January 1984,
Bratislavske lekarske listy,
A Bucciero, and
E Molteni, and
B Molteni, and
W Mariani, and
M Jacobellis
January 1979,
Gynecologie,
A Bucciero, and
E Molteni, and
B Molteni, and
W Mariani, and
M Jacobellis
November 1976,
Semaine des hopitaux. Therapeutique,
A Bucciero, and
E Molteni, and
B Molteni, and
W Mariani, and
M Jacobellis
January 1977,
Wiener medizinische Wochenschrift (1946),
